anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

229,741-229,800 of 319,975

filter-aware
05
The slide uses a chevron-based layout to categorize key company pillars.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
06
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TeamLoop · Golden Circle1 hit
07
The slide is split into two sections: individual board member profiles and a grid of investor logos.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TeamLoop · Golden Circle1 hit
08
The chart uses a Gantt-style visualization to represent clinical trial phases for different indications.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
09
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · Market SizeLoop · Golden Circle1 hit
10
The slide uses a Kaplan-Meier curve to visually demonstrate the 'problem' (rapid progression) and a callout box to quantify the market opportunity.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide features a stylized 3D rendering of a cell, likely representing the therapeutic target or mechanism of action.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
12
Includes Kaplan-Meier survival curves and a summary table of clinical outcomes.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a process flow diagram to illustrate the clinical trial stages.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
14
The slide uses a comparison table to contrast clinical trial data for CRG-022 against historical benchmarks for ZUMA-1, JULIET, and TRANSCEND.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
15
Kaplan-Meier survival curve shown.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
16
The slide outlines the methodology for a clinical trial, specifically detailing the patient population and treatment protocol.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
17
The table uses checkmarks to indicate which strategic principles impact specific operational metrics.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
18
The slide uses a biological schematic to explain the mechanism of action and key design features of the therapeutic candidate.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
Features a stylized 3D rendering of a cell, likely representing CAR-T or similar cellular therapy.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
20
The slide uses a problem-solution mapping framework to explain the therapeutic approach.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
21
The slide uses a biological mechanism diagram, a Kaplan-Meier survival curve, and IHC images to demonstrate the clinical impact of CD58 loss.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
22
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
23
The slide uses a funnel diagram to represent the screening process and bar charts to demonstrate specificity across CD19, CD20, and CD22 targets.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
24
Data shows bioluminescent flux over time; CRG-023 consistently reduces tumor burden to baseline.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
25
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
26
The slide uses a matrix structure to categorize therapies by modality and development stage, highlighting CARGO's specific positioning.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
27
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
28
Includes investor logos, financial metrics, and a timeline of clinical milestones.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
29
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
01
Slide 1
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
02
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
03
This is a standard IPO 'deal terms' slide.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
04
The slide uses a grid layout for five executive profiles, each including a headshot, title, brief bio, and relevant company logos.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Team1 hit
05
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
06
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
07
Uses a comparative diagram to illustrate the biological mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a circular process diagram overlaid on a cross-section of a bladder to explain the treatment steps.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
09
Uses a before-after framing to explain the mechanism of action for the DDM surfactant.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a biological process flow to explain the therapeutic mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
11
The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The diagram shows the progression of tumor invasion through the bladder wall layers (Lamina Propria, Inner Muscle, Deep Muscle).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
13
The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
16
Includes FDA Fast Track and Breakthrough Therapy designations.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
17
BOND-003 study data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
18
Efficacy data cutoff as of October 5, 2023. Footnote indicates some patients excluded from 6-month assessment.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
19
The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
20
BOND-003 clinical trial safety data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
21
The slide explicitly notes that these are not head-to-head studies.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
22
The slide uses a process-flow style layout to define the clinical trial parameters.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
23
The slide uses a swimmer plot to visualize patient-level clinical trial data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
24
The table lists specific medical conditions (Preferred Terms) and their occurrence rates across 35 patients.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
25
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
26
PIVOT-006 trial design slide.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
27
The slide uses a process-flow layout to define the clinical trial structure.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
28
The slide uses a hierarchical tree structure to map patient risk categories to specific clinical trial programs (PIVOT-006, CORE-008, BOND-003, CORE-001).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
29
CMC stands for Chemistry, Manufacturing, and Controls.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
30
The slide uses a grid of four headshots with biographical details and company logos for each member.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
31
The slide uses a circular process flow graphic to represent a sequential commercialization strategy.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
32
The diagram uses a hub-and-spoke model to show how various commercial roles interact with the central customer entities (LUGPA and Hospitals).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
33
The slide uses a grid-based timeline layout to map specific clinical trial milestones (stars) against time periods.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
34
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
35
This is a standard contact/footer slide often found at the end of a pitch deck.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit